Literature DB >> 20164601

NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide.

Nanditha G Nair1, George Perry, Mark A Smith, V Prakash Reddy.   

Abstract

Amyloid-beta (Abeta), the major component of senile plaques in Alzheimer's disease, is known to complex transition metal ions mainly through histidine residues. In this study, using 1H NMR titration experiments, we show that histidine binds strongly to Zn(II), Cu(II), and Fe(III) ions at a biologically relevant pH (pH 7.4), with a stoichiometry of Zn(II): histidine binding of 1:2. The observed deshielding of the chemical shifts and relative line broadening indicate that Fenton-active Cu(II) and Fe(III) bind to histidine relatively more efficiently as compared to Zn(II). Parallel studies showed that glutamic acid and aspartic acid are relatively inefficient in metal ion binding. From these studies, we suggest that Abeta-chelated Zn(II) is readily displaced by Cu(II) and Fe(III) ions and leads to a propagation of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164601     DOI: 10.3233/JAD-2010-1346

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

Review 1.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

2.  Iron increases APP translation and amyloid-beta production in the retina.

Authors:  Lucie Y Guo; Oleg Alekseev; Yafeng Li; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2014-10-16       Impact factor: 3.467

3.  Probing of various physiologically relevant metals-amyloid-β peptide interactions with a lipid membrane-immobilized protein nanopore [corrected].

Authors:  Alina Asandei; Sorana Iftemi; Loredana Mereuta; Irina Schiopu; Tudor Luchian
Journal:  J Membr Biol       Date:  2014-04-09       Impact factor: 1.843

4.  Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation.

Authors:  Wei-Ting Chen; Yi-Hung Liao; Hui-Ming Yu; Irene H Cheng; Yun-Ru Chen
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

Review 5.  Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.

Authors:  Maire E Percy; Theo P A Kruck; Aileen I Pogue; Walter J Lukiw
Journal:  J Inorg Biochem       Date:  2011-08-19       Impact factor: 4.155

6.  Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.

Authors:  Maluta S Mufamadi; Yahya E Choonara; Pradeep Kumar; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Lisa C du Toit; Sunny E Iyuke; Viness Pillay
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

7.  Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.

Authors:  Beinan Liu; Aileen Moloney; Sarah Meehan; Kyle Morris; Sally E Thomas; Louise C Serpell; Robert Hider; Stefan J Marciniak; David A Lomas; Damian C Crowther
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

8.  Histidine protects against zinc and nickel toxicity in Caenorhabditis elegans.

Authors:  John T Murphy; Janelle J Bruinsma; Daniel L Schneider; Sara Collier; James Guthrie; Asif Chinwalla; J David Robertson; Elaine R Mardis; Kerry Kornfeld
Journal:  PLoS Genet       Date:  2011-03-24       Impact factor: 5.917

9.  Neuronal and vascular oxidative stress in Alzheimer's disease.

Authors:  Cynthia A Massaad
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

10.  Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces.

Authors:  Francis Hane; Gary Tran; Simon J Attwood; Zoya Leonenko
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.